drugset
drugset / Trial / NCT03624517

Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices

NCT03624517 ↗

Phase 4 Terminated 34 enrolled Medical University of South Carolina Ohio State University · collabUniversity of Florida Health · collabUniversity of Texas Southwestern Medical Center · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

This study evaluates the safety and efficacy of 24-hour vs 72-hour octreotide infusion after variceal banding in cirrhotic patients with bleeding esophageal varices.

Timeline

Start
2018-09-19
Primary completion
2024-12-01
Completion
2024-12-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Octreotide Peptide — —

Indications

cirrhosis of liver esophageal varices with bleeding